Common Medications Which Should Be Stopped Prior to Platelet-Rich Plasma Injection
Osteoarthritis (OA) is an extremely prevalent joint condition in the United States, affecting over 30 million people [...]
Main Authors: | Ashim Gupta, Madhan Jeyaraman, Nicola Maffulli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/9/2134 |
Similar Items
-
Allogenic platelet-rich plasma for treatment of knee and hip osteoarthritis
by: Ashim Gupta, et al.
Published: (2023-06-01) -
Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis
by: Ashim Gupta, et al.
Published: (2023-01-01) -
Platelet-Rich Plasma One Week Prior to Hyaluronic Acid vs. Platelet-Rich Plasma Alone for the Treatment of Knee Osteoarthritis
by: Ashim Gupta
Published: (2022-11-01) -
Management of rotator cuff injuries using allogenic platelet-rich plasma
by: Ashim Gupta, et al.
Published: (2024-03-01) -
Red Blood Cells in Platelet-Rich Plasma: Avoid If at All Possible
by: Ashim Gupta, et al.
Published: (2023-08-01)